Multiple class action lawsuits allege that Mielle Organics LLC and its parent company, The Procter & Gamble Company, failed to warn consumers that the Rosemary Mint Scalp & Strengthening Hair Oil and related products in the Rosemary Mint line carry a high risk of causing hair loss, scalp irritation, blistering, and breakage. The complaints, filed by consumers across the country beginning in November 2024, assert that Mielle marketed the products as safe and effective for hair growth while concealing known or knowable risks in the formulation.
The primary case, Williams et al. v. Mielle Organics LLC et al., Case No. 1:24-cv-12763, is pending in the U.S. District Court for the Northern District of Illinois. A separate California case, Allen v. Mielle Organics LLC, Case No. 8:25-cv-00342, filed February 21, 2025, focuses on false “Made in USA” and “natural ingredients” labeling. Both cases are ongoing, with no settlement reached and no class certified as of June 2026.
- What: Class action lawsuits allege Mielle Organics Rosemary Mint hair oil and related products cause hair loss, scalp burns, and breakage without adequate warning
- Who: Plaintiffs Stephanie Williams, Krista Gillette, Georgina Gomes (Illinois) and Sharon Allen (California) vs. Mielle Organics LLC and The Procter & Gamble Company
- Status: Active and ongoing — Illinois case survived initial motion to dismiss; California labeling case pending; no settlement reached
- Injuries: Hair loss, excessive shedding, bald patches, scalp blistering, sores, and permanent follicle damage
- Settlement: Pending — no approved settlement, no claim form, no payout program exists as of June 2026
- Eligibility: Anyone who purchased Mielle Organics Rosemary Mint products in the United States within the applicable statute of limitations
- Key date: December 12, 2024 — consolidated multi-plaintiff complaint filed in the Northern District of Illinois
Mielle Organics Lawsuit Timeline and Updates
January 2023 — Procter & Gamble Acquires Mielle Organics
On January 11, 2023, Monique Rodriguez, the founder and CEO of Mielle Organics, announced that she had sold the brand to P&G Beauty, a division of The Procter & Gamble Company. Rodriguez, a former nurse from Chicago, had founded Mielle Organics in 2014, building it into a leading hair care brand for textured and natural hair. The brand’s Rosemary Mint Scalp & Strengthening Hair Oil had become its flagship product, popularized heavily on social media.
The acquisition triggered immediate backlash in the Black hair care community, with consumers expressing concern that a corporate owner would change the formula or shift the brand’s focus. Rodriguez publicly assured customers on Instagram that the formulas would remain unchanged. She described the deal not as a sellout but as a “sell-up,” designed to give her brand greater resources and reach while remaining Black-led as an independent subsidiary of P&G Beauty. Rodriguez and her husband Melvin Rodriguez, the brand’s co-founder and COO, both remained in their leadership roles.
Early 2023 — Viral TikTok Controversy Over Hair Loss
Shortly before the P&G acquisition announcement, the Rosemary Mint Oil had gone viral after white influencer Alix Earle posted a video about the product to her large TikTok following, driving a surge in purchases from outside the brand’s traditional customer base. This created what some observers called a supply pressure concern and sparked criticism about the “Black hair tax,” a term referring to the tendency for products developed for Black hair to be priced higher or made less accessible once they gain mainstream appeal.
As hair loss complaints accumulated on social media in late 2023 and into 2024, some consumers and influencers attributed the problem to alleged formula changes following the P&G acquisition. Licensed cosmetologist and hair influencer Danesha Mo’nek posted a TikTok video on September 2, 2024, describing how the Rosemary Mint Oil inflamed her scalp and caused hair loss in chunks, drawing nearly 80,000 views and sparking a broader wave of consumer complaints online.
September 7, 2024 — Monique Rodriguez Issues Public Statement
Facing mounting social media criticism, Rodriguez issued a video statement on Instagram on September 7, 2024, denying any formula change since the product’s introduction. She stated that her entire family uses Mielle products daily and urged skeptical consumers to compare ingredient lists from 2019 through the present to verify no change had occurred. Critics responded in the comments that her statement did not address the specific hair loss complaints, and consumer reports of damage continued appearing across TikTok, YouTube, and legal news sites through the end of 2024.
On November 22, 2024, Rodriguez escalated the dispute by posting a video identifying what she described as a content creator who had been paid by a competitor to spread misinformation about Mielle products. She claimed that creator had manufactured or amplified the hair loss controversy for commercial gain. Rodriguez did not name the creator publicly. Beauty Independent, reporting on the controversy, identified the creator Rodriguez appeared to reference as Danesha Mo’nek, the TikTok influencer whose September video had gone viral.
November 21, 2024 — First Class Action Filed in Illinois
Plaintiff Georgina Gomes, a Massachusetts resident, filed the first class action complaint against Mielle Organics LLC and The Procter & Gamble Company on November 21, 2024, in the U.S. District Court for the Northern District of Illinois, Case No. 1:24-cv-12019. Gomes alleged that she purchased the Rosemary Mint Scalp & Strengthening Hair Oil after being influenced by the product’s marketing claims of hair strengthening and growth support, and that the product instead caused significant hair loss. The complaint asserted violations of the Illinois Consumer Fraud and Deceptive Business Practices Act, along with fraud and unjust enrichment claims.
December 11–12, 2024 — Cases Consolidated Into Multi-Plaintiff Complaint
The original Gomes complaint was voluntarily dismissed on December 11, 2024. The following day, on December 12, 2024, three plaintiffs — Stephanie Williams, Krista Gillette, and Georgina Gomes — filed a consolidated multi-plaintiff complaint in the Northern District of Illinois, Case No. 1:24-cv-12763, representing the lead vehicle for the hair loss litigation. All three plaintiffs reported experiencing hair loss, excessive shedding, bald patches, scalp sores, and blistering from using products in the Mielle Rosemary Mint line. The consolidated complaint named both Mielle Organics LLC and The Procter & Gamble Company as defendants and sought to certify a nationwide class of consumers who purchased the affected products.
Early 2025 — Defendants’ Motion to Dismiss Granted Without Prejudice
Mielle Organics and Procter & Gamble filed a motion to dismiss the Williams consolidated complaint. The court granted the motion to dismiss without prejudice, giving the plaintiffs two weeks to file an amended complaint. The dismissal without prejudice means the lawsuit was not ended, only that the original complaint needed additional factual allegations or legal framing to survive at the pleading stage. As of mid-2025, the case remained active in the Northern District of Illinois as plaintiffs worked to strengthen their claims through amended filings and ongoing discovery.
February 21, 2025 — California Labeling Lawsuit Filed
Plaintiff Sharon Allen filed a separate class action complaint on February 21, 2025, in the U.S. District Court for the Central District of California, Case No. 8:25-cv-00342. This case raises different allegations from the Illinois hair loss claims. Allen asserts that Mielle Organics falsely marketed its products as “Made in USA” and as containing natural ingredients, when in reality the products contain synthetic components and foreign-sourced ingredients such as tea tree oil and coconut oil. The complaint further alleges that Mielle’s health and growth claims, including those related to dandruff relief and hair strengthening, lack scientific substantiation. The California case was assigned to U.S. District Judge Fred W. Slaughter and Magistrate Judge Karen E. Scott, and remains pending as of June 2026.
2026 — Cases in Active Discovery, No Settlement Reached
As of June 2026, both principal cases remain in active litigation. No settlement has been announced, no claim form has been opened, and no class has been formally certified. The Williams case in Illinois is working through post-dismissal amended pleadings, and the Allen case in California is in early procedural stages. Legal analysts project resolution in the 2026 to 2027 timeframe, consistent with the typical two-to-four-year timeline for consumer product class actions at this procedural stage.
What the Lawsuits Allege
The Illinois hair loss complaints center on a product liability and false advertising theory: that the Mielle Organics Rosemary Mint line contains ingredients that cause or risk causing hair loss, that Mielle and P&G knew or should have known this through adequate product testing, and that both companies failed to warn consumers anywhere on product labeling, packaging, or marketing materials about this risk.
The consolidated complaint in Williams et al. specifically targets four products in the Rosemary Mint line: the Scalp & Strengthening Hair Oil, the Strengthening Shampoo, the Strengthening Conditioner, and the Deep Conditioner. Plaintiffs allege that the products were sold with representations that they strengthen hair strands, nourish the scalp, and support hair growth, while actually containing ingredients that posed a high risk of the opposite outcome.
The complaint argues that no reasonable consumer would have purchased the products, or would have paid the price charged, if they had been warned that the products carried a risk of causing hair loss. It seeks compensatory and punitive damages, full refunds, and injunctive relief requiring Mielle and P&G to add risk disclosures to product labeling and halt sales of products without those disclosures. Claims include fraud, unjust enrichment, and violations of state consumer fraud statutes.
The California case in Allen v. Mielle Organics frames the controversy differently. Allen argues that Mielle’s marketing creates a false impression of domestic manufacturing and purely natural formulations, misleading consumers who pay a premium specifically for those attributes. She argues that health and scalp benefit claims on Mielle products, including growth support and dandruff reduction, are unsubstantiated by scientific evidence and constitute deceptive advertising under California’s False Advertising Law and Consumers Legal Remedies Act.
The Ingredients Under Scrutiny
The Mielle Organics Rosemary Mint Scalp & Strengthening Hair Oil contains a concentrated blend of botanical essential oils and extracts. The full ingredient list includes soybean oil, castor seed oil, rosemary leaf oil, jojoba seed oil, peppermint oil, eucalyptus leaf oil, menthol, tea tree leaf oil, coconut oil, horsetail extract, aloe barbadensis extract, lavender oil, wheat germ oil, safflower seed oil, evening primrose oil, grape seed oil, benzyl nicotinate, sweet almond oil, rice bran oil, tocopheryl acetate, biotin, burdock root extract, glycerin, celery seed extract, vitamins A, C, and D, basil oil, patchouli oil, and sage oil, among others.
The lawsuits do not isolate a single ingredient as definitively causative. Plaintiffs allege that the combination and concentration of certain ingredients, particularly the essential oils and menthol, may cause scalp irritation in susceptible individuals and, through repeated use, may trigger or worsen hair loss. Dermatologists and hair loss specialists note that high concentrations of peppermint oil, menthol, and eucalyptus can cause contact dermatitis on the scalp in sensitive individuals, and that prolonged scalp inflammation from any irritant can disrupt the hair growth cycle and lead to shedding.
Plaintiffs further argue that Mielle and P&G failed to conduct adequate quality assurance testing to identify these risks before marketing the products. Had proper testing occurred, the complaints contend, the problematic ingredients or concentrations would have been detected and either reformulated or accompanied by risk disclosure language on product packaging.
| Case | Court | Filed | Core Allegation | Status |
|---|---|---|---|---|
| Williams et al. v. Mielle Organics | N.D. Ill. (1:24-cv-12763) | Dec. 2024 | Hair loss from Rosemary Mint line | Active — post-dismissal amendment phase |
| Allen v. Mielle Organics | C.D. Cal. (8:25-cv-00342) | Feb. 2025 | False “Made in USA” / unsubstantiated claims | Active — early pleading stage |
The Social Media Scale of Consumer Complaints
What distinguishes the Mielle litigation from many product liability cases is the sheer volume and specificity of consumer complaints documented publicly before any lawsuit was filed. Hundreds of users posted videos and written accounts on TikTok, YouTube, Instagram, and consumer complaint sites describing remarkably similar experiences: hair shedding in clumps during washing and combing, loss of edges (the hairline hair particularly prized in Black hair care), bald patches forming at the crown or along the scalp, and a change in hair texture described as dry, brittle, or Brillo-like.
Legal news sites that solicited reader comments received accounts from hundreds of consumers between late 2024 and mid-2025, many describing years of product use followed by sudden, dramatic changes. Some reported having used Mielle products since before the P&G acquisition with no problems, then experiencing hair loss in the months following the acquisition, fueling the formula-change theory. Others described adverse reactions from their first use.
Rodriguez’s response attributing the controversy to a competitor-sponsored influencer campaign did not halt the flow of consumer reports. Consumer advocates and legal commentators noted that regardless of whether any single creator was paid to criticize the brand, the volume and consistency of independent reports from diverse consumers across the country supported the existence of a real adverse reaction pattern warranting investigation.
What P&G Acquiring Mielle Means for the Lawsuit
The Procter & Gamble Company’s January 2023 acquisition of Mielle Organics substantially changes the legal calculus of the class action. As the parent company and ultimate owner of Mielle Organics LLC, P&G bears potential liability for both pre- and post-acquisition product claims. All three plaintiffs in the consolidated Illinois complaint, and the California plaintiff in Allen, specifically name P&G as a co-defendant alongside Mielle Organics LLC.
P&G is one of the world’s largest consumer goods companies, with the financial resources to defend prolonged litigation but also with significant reputational exposure around consumer safety claims for a brand it markets to the Black hair care community. The acquisition created expectations among consumers that P&G’s resources would bring rigorous safety testing to Mielle products. If the lawsuits establish that P&G failed to apply its standard quality assurance protocols to the Rosemary Mint line after acquisition, that failure could weigh heavily in damages calculations.
P&G and Mielle have denied wrongdoing. The companies maintain that the products are safe when used as directed and that individual reactions vary based on pre-existing scalp conditions, underlying hair loss conditions such as alopecia, and individual sensitivities. Neither company has issued a product recall or reformulated the Rosemary Mint line in response to the complaints or the lawsuits. The products remain on shelves at Target, CVS, Walgreens, Walmart, and other major retailers as of June 2026.
Who Qualifies to Join the Mielle Class Action
- Purchased Mielle Organics Rosemary Mint Scalp & Strengthening Hair Oil or other Rosemary Mint line products in the United States
- Purchase occurred within the applicable statute of limitations (typically 2–5 years, depending on the state and claim type)
- Experienced hair loss, excessive shedding, bald patches, scalp irritation, blistering, or sores following product use
- Would not have purchased the product, or would have paid less, had you been warned about the risk of hair loss
The consolidated Illinois lawsuit seeks to certify a nationwide class covering all U.S. consumers who purchased Mielle Organics Rosemary Mint Scalp & Strengthening Hair Oil for personal or household use within the applicable statute of limitations period. The proposed class does not require that members experienced hair loss — it also includes consumers who paid a premium for a product that carried an undisclosed hair loss risk, making all purchasers potentially eligible for economic damages based on overpayment.
Consumers who experienced documented physical harm, including significant hair loss, bald patches, or scalp damage, may have stronger claims and may be positioned for higher individual recovery than consumers whose damages are limited to economic overpayment. Individuals with severe or permanent hair loss from the product may want to consult an attorney about whether an individual product liability claim, rather than participating in the class action, would better serve their interests.
How Mielle Fits Into the Broader Black Hair Care Industry Context
The Mielle controversy is part of a longer pattern in the Black hair care industry. Consumers and advocates have raised concerns for years about the safety of chemical formulations in products marketed specifically for Black and textured hair, including the hair relaxer lawsuits that have grown into one of the most significant product liability cases in the country, similarly involving women of color, hair loss, and cancer. Similar to the Tampax lead lawsuit, where a product trusted by women for intimate hygiene was alleged to carry undisclosed contamination risks, the Mielle lawsuit raises questions about how rigorously beauty companies test products before placing them on the market with health claims.
The Mielle case also intersects with broader debates about what happens to community-rooted beauty brands when they are acquired by large corporations. Consumer concern that the P&G acquisition preceded or caused the formula and quality changes alleged in the lawsuits reflects a documented history in the industry, where brands like Carol’s Daughter, Shea Moisture, and others saw community skepticism following corporate acquisitions. Whether formula changes actually occurred in the Mielle case remains contested. What is established is that a significant number of consumers began reporting the same adverse reactions after a period that coincides with the P&G acquisition.
The California labeling case adds a second dimension that is increasingly common in natural and organic beauty litigation. The Federal Trade Commission has long required that “Made in USA” claims apply only to products where all or virtually all content is domestically produced. When key botanical ingredients like tea tree oil and coconut oil are sourced internationally, the “Made in USA” claim faces legal scrutiny. Similarly, FDA guidance on cosmetic claims prohibits structure-function claims that imply therapeutic benefit, meaning phrases like “strengthens strands” and “nourishes scalp” must be carefully substantiated. The Allen case tests whether Mielle’s marketing language crosses those lines.
What Plaintiffs Are Asking Courts to Order
The Illinois hair loss plaintiffs seek compensatory damages for money paid for products that caused harm or carried undisclosed risks, statutory damages under applicable state consumer fraud acts, punitive damages designed to punish defendants for knowing or reckless concealment of risks, full refunds for all class members who purchased the Rosemary Mint line, and injunctive relief requiring Mielle and P&G to add clear risk disclosure language to product labels and to halt sales of the current formulation without those disclosures. They also request court-ordered quality assurance reforms and independent third-party testing of the challenged products.
The California plaintiff in Allen seeks similar monetary damages for the “Made in USA” and natural ingredients deception, plus an injunction against the allegedly false advertising claims. She requests that Mielle stop using the “Made in USA” designation and remove unsubstantiated health benefit claims from product packaging and marketing materials unless supported by scientific evidence.
What This Lawsuit Teaches Consumers
The Mielle lawsuits illustrate a regulatory gap specific to the cosmetics and personal care industry. Unlike pharmaceuticals, which require clinical trials and FDA approval before reaching consumers, cosmetics in the United States are not required to undergo pre-market safety testing. Manufacturers are responsible for ensuring their own products are safe, but there is no mandatory pre-sale review by any federal agency. The FDA regulates cosmetics primarily through post-market surveillance, meaning problems often surface only after consumers have already been harmed.
This gap is especially consequential for personal care products that contact sensitive tissue, are used repeatedly over months or years, or are applied directly to the scalp in concentrations that may exceed what any single clinical study would test. Essential oils like peppermint, tea tree, and eucalyptus are generally recognized as safe at appropriate concentrations, but their interaction with individual scalp chemistry, underlying dermatological conditions, and combined use with other products is rarely tested before products reach store shelves.
The consumer lesson embedded in the Mielle controversy is that “natural” and “strengthening” on a label are marketing claims, not safety certifications. A product built around rosemary oil, biotin, and plant extracts carries no more inherent safety guarantee than one built around synthetic chemicals. What matters is concentration, formulation quality, and whether the manufacturer tested the finished product across a representative range of users before making it available for sale. The lawsuits allege Mielle did not. The courts will determine whether that allegation holds up, and what it means for the tens of thousands of consumers who say they lost their hair trusting it.
Read These
- Tampax Pearl lead contamination lawsuit
- Brita water filter false advertising lawsuit
- PNC Bank data sharing lawsuit
- Fireball whisky fraud lawsuit
- Strava Garmin patent lawsuit
Frequently Asked Questions
What is the current status of the Mielle Organics lawsuit?
As of June 2026, two class actions are active. Williams et al. v. Mielle Organics (N.D. Ill.) is in an amended pleading phase after the court granted a motion to dismiss without prejudice. Allen v. Mielle Organics (C.D. Cal.) is in early procedural stages. No settlement exists.
Do I qualify to join the Mielle hair loss class action?
You likely qualify if you purchased Mielle Organics Rosemary Mint products in the U.S. within the applicable statute of limitations. You do not need to have experienced hair loss — purchasers who overpaid for a product with undisclosed risks may also be included. Consult an attorney if you experienced significant harm.
What injuries are covered by the Mielle lawsuit?
The lawsuits cover hair loss, excessive shedding, bald patches, scalp blistering, sores, burning sensations, and hair breakage following use of Mielle Organics Rosemary Mint hair oil, shampoo, conditioner, and deep conditioner.
How much could I receive from a Mielle settlement?
No settlement exists yet. Legal analysts estimate consumer fraud class actions of this type typically yield $50–$300 for minor economic claims per purchase. Consumers with documented significant hair loss or scalp injury may seek higher individual recovery. No payout figures are confirmed.
Who owns Mielle Organics?
The Procter & Gamble Company acquired Mielle Organics in January 2023. Founder Monique Rodriguez and her husband Melvin Rodriguez remain as CEO and COO, operating Mielle as an independent subsidiary of P&G Beauty. Both Mielle Organics LLC and P&G are named defendants in the lawsuits.
Did Mielle Organics change the formula after the P&G acquisition?
Mielle Organics and Monique Rodriguez have publicly and repeatedly stated there were no formula changes following the P&G acquisition. Plaintiffs dispute this and allege the products as formulated — whether changed or not — contain ingredients that cause hair loss risks that were never disclosed.
What products are named in the Mielle lawsuit?
The consolidated Illinois lawsuit specifically targets the Rosemary Mint Scalp & Strengthening Hair Oil, Rosemary Mint Strengthening Shampoo, Rosemary Mint Strengthening Conditioner, and Rosemary Mint Deep Conditioner. The oil is the most frequently cited product.
What is the statute of limitations for the Mielle lawsuit?
The statute of limitations varies by state and claim type. Consumer fraud claims in Illinois typically carry a 5-year window. California consumer protection claims carry a 3-to-4-year window. Consumers who purchased Mielle products back to approximately 2020–2021 may be within the limitations period.
Can I still file a claim if I threw away the product packaging?
Yes, for class action purposes. Consumers typically need to show they purchased the product during the class period but are not required to have retained packaging. Bank records, store loyalty card history, and receipts can document purchases. Physical evidence strengthens individual injury claims.
What is the Allen v. Mielle Organics California lawsuit about?
The California case, filed February 2025, focuses on labeling rather than hair loss. It alleges Mielle falsely markets products as ‘Made in USA’ and as containing only natural ingredients, when the products contain synthetic components and internationally sourced botanical ingredients like tea tree and coconut oil.
Has Mielle Organics issued a product recall?
No. Neither Mielle Organics nor Procter & Gamble has issued a product recall for the Rosemary Mint line. The products remain available at major retailers including Target, CVS, Walgreens, and Walmart as of June 2026.
What should I do if I experienced hair loss from Mielle products?
Document your experience with photos showing hair loss progression, retain any product you still have, gather proof of purchase if possible, and consult a dermatologist to assess your scalp and hair loss. If your hair loss was significant, consult an attorney to evaluate whether you have a stronger individual claim in addition to potential class action participation.
Leave a Reply